Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of gemfibrozil in modulating
microRNA-107 levels for the prevention of Alzheimer's disease in subjects with intact
cognition and mild cognitive impairment